RCON Recon Technology Ltd posts far narrower Q4 2025 loss than estimates shares rise 225 percent in todays trading KALU Kaiser smashes Q1 estimates with 374 EPS nearly doubling forecasts on strong aluminum demand SEER Seer sustains growth momentum with Q4 revenue up 156 but shares slip despite EPS beat Boston Scientific Corporation BSX Neuromodulation Segment Drives Strong Q1 Performance Amid Market Volatility SNPS Synopsys Inc Q1 2026 earnings top consensus shares jump nearly five percent on strong double digit revenue growth How sustainable is AEye LIDR profit margins Advances 20260508 Invitation Homes INVH Stock Earnings Whisper 004 20260416 PGNY Progyny shares surge 238 after fertility benefits firm crushes earnings with 64 EPS beat KnightSwift KNX Stock Trendline Structure Analysis At Highs 20260418 Telekom Malaysia Berhad TM Weak Statutory Earnings Understate Core Profitability Headwinds Should I buy Ryerson RYZ stock Smart Money Flows 20260420 Is Linkage LGCB stock a logical buy right now Earnings Report Saga SGA Stock Is It a Strong Investment Case Saga posts 107 per share loss 2748 negative EPS miss BPYPM Bkfield Pref releases no finalized quarterly earnings data as investors await upcoming operational guidance Fidelity MSCI Consumer Discretionary Index ETF FDIS Positioning for Consumer Resilience Amid Geopolitical Inflation Volatility NWPX Infrastructure NWPX Growth Potential NWPX Infrastructure posts 436 EPS beat on strong project delivery VS Media VSME Stock Momentum Play Technical Strength 20260420 Cantor Equity CEPO Stock Profit Margins 009 20260420 Fenbo FEBO Stock VWAP Break Weakens 20260420 ZYME Zymeworks shares edge higher after Q4 2025 revenue jumps 389 year over year despite earnings miss ESCO Technologies ESE Stock Systematic Trade Technical Weakness 20260415 KLRS Kalaris Therapeutics Inc reports narrower Q4 2025 loss than expected shares post mild gains after earnings release STMicroelectronics NV STM Stock Market Sentiment 054 20260415 DWTX Dogwood Therapeutics Inc posts far narrower Q4 2025 loss than consensus estimates yet shares dip 447 today HLMN Hillman Solutions posts Q4 2025 earnings above estimates with stock climbing on solid yearoveryear revenue growth CNO Fin CNO Stock Is It a Strong Buy CNO Fin posts 206 pct EPS beat topping estimates Harvard Bioscience HBIO Quarterly Preview Q4 2025 Below Expectations Why Ironwood Pharmaceuticals IRWD ability to innovate sets it apart Market Focus 20260508 Corbus CRBP Stock Foreign Investment Overhead Buying 20260416